GlassScriptPhysician profile
Jason Song
NPI 1205074002
$19,208.47
in general payments reported to CMS, 2019-2025
37 companies · $3,917 in 2025
The $3,917 reported for 2025 was more than what 89% of Pain Medicine providers received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,877 · 2020: $2,228 · 2021: $1,957 · 2022: $3,562 · 2023: $3,774 · 2024: $1,893 · 2025: $3,917.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,167 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,710 · Travel and Lodging: $1,610 · Education: $97.78.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,166.54 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,710.00 |
| Travel and Lodging | $1,610.49 |
| Education | $97.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $8,213.51 | 2021-2025 | Intellis Adaptivestim, Synchromedii, Kyphon Express II Kyphopak Tray |
| Medtronic USA, INC. | $2,495.09 | 2019-2020 | |
| Nevro Corp. | $1,973.67 | 2019-2024 | Senza |
| Curonix LLC | $1,130.81 | 2022-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Boston Scientific Corporation | $735.84 | 2019-2025 | Intracept, Wavewriter Alpha Prime 16, Infinion 16 |
| Biotronik Nro, INC. | $588.06 | 2025 | Prospera |
| Relievant Medsystems, INC. | $516.81 | 2019-2023 | Intracept |
| Vertos Medical, INC. | $493.64 | 2022-2024 | Mild Device Kit |
| Abbott Laboratories | $409.61 | 2019-2025 | Axium, Eterna, Proclaim |
| Stimwave Technologies Incorporated | $392.96 | 2021-2022 | |
| Globus Medical, INC. | $284.43 | 2025 | Senza |
| Scilex Pharmaceuticals INC. | $249.91 | 2021-2024 | Ztlido |
| Protega Pharmaceutials INC | $227.14 | 2022-2025 | Roxybond |
| Nutech Spine, INC. | $222.16 | 2020 | |
| Saluda Medical Americas, INC. | $209.11 | 2024-2025 | Evoke |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $183.03 | 2021-2025 | Ubrelvy |
| Spr Therapeutics, INC | $111.21 | 2023-2024 | Sprint Pns System |
| Flowonix Medical Incorporated | $90.73 | 2020 | |
| Daiichi Sankyo INC. | $76.71 | 2019 | |
| Pfizer INC. | $73.86 | 2023-2024 | |
| Biodelivery Sciences International, INC. | $63.39 | 2019-2021 | |
| Kowa Pharmaceuticals America, INC. | $57.79 | 2022 | |
| West Therapeutics Development, LLC | $57.26 | 2019-2021 | |
| Bioventus LLC | $56.94 | 2020-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $35.46 | 2022 | |
| Tersera Therapeutics LLC | $34.79 | 2021 | |
| Allergan, INC. | $25.87 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $24.41 | 2025 | |
| Ibsa Pharma INC. | $24.13 | 2024 | Tirosint, Licart |
| Averitas Pharma INC. | $24.11 | 2023 | Qutenza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $21.04 | 2025 | Relistor |
| Hikma Pharmaceuticals USA | $21.00 | 2022 | |
| Spinal Simplicity, LLC | $19.76 | 2024 | Ha Minuteman G3-R |
| Avanos Medical | $18.02 | 2021 | |
| Painteq LLC | $16.49 | 2021 | |
| Metacel Pharmaceuticals LLC | $16.46 | 2022 | |
| Foundation Fusion Solutions, LLC | $13.26 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Song listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.